Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Phenylephrine Drugs Market?

In recent times, the phenylephrine drugs market has witnessed a swift expansion. It’s predicted that the market size will escalate from $25.44 billion in 2024 and reach $28.03 billion by 2025, maintaining a compound annual growth rate (CAGR) of 10.2%. The market’s previous growth trends can be linked to the heightened occurrence of cold and flu, an increase in cases of allergic rhinitis, a surging demand for over-the-counter drugs, a rise in self-medication habits, and a growing number of surgical procedures.

What Growth Rate Is Forecasted for the Phenylephrine Drugs Market by 2029?

The market size for phenylephrine drugs is forecasted to experience substantial growth in the upcoming years. It is expected to reach a value of $40.83 billion by 2029 with a compound annual growth rate (CAGR) of 9.9%. The growth anticipated during the forecast period can be attributed to increased spending on healthcare in emerging markets, the drug’s increasing use in critical care to treat hypotension, a growing aged population, heightened awareness of nasal cleanliness, and broader access to combination therapies. The key trends predicted for the forecast period include advancements in the delivery of nasal drugs, technological enhancements for formulation stability, the development of high-tech nasal spray formulations, the introduction of combination drug-device platforms, and digital monitoring for over the counter medication usage.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24655&type=smp

Which Key Companies Are Shaping the Future of the Phenylephrine Drugs Market?

Major companies operating in the phenylephrine drugs market are Pfizer Inc., Procter And Gamble Co., Johnson And Johnson Consumer Inc, Bayer AG, GlaxoSmithKline PLC, Sandoz Group AG, Hikma Pharmaceuticals USA, Siegfried AG, Perrigo Company PLC, Amneal Pharmaceuticals LLC, Civica, Xellia Pharmaceuticals USA LLC, Camber Pharmaceuticals, Exela Pharma Sciences, Eton Pharmaceuticals, SOLA Pharmaceuticals, Fresenius Kabi USA, Somerset Therapeutics, Meitheal Pharmaceuticals, Novadoz Pharmaceuticals LLC

Which Factors Are Driving Demand in the Phenylephrine Drugs Industry?

The phenylephrine drugs market is predicted to grow due to an increase in respiratory illnesses. These illnesses encompass any complications or disorders that affect the lungs, airways, and other parts of the respiratory system. This mounting incidence is primarily fueled by the surge in air pollution, which harms lung tissue, decreases respiratory operations, and instigates conditions like asthma. Phenylephrine drugs serve as a significant aid in combatting these diseases as they act as nasal decongestants, narrowing the blood vessels in nasal passages. This reduces swelling and enhances airflow, relieving typical symptoms like nasal congestion, sinus pressure, and breathing difficulties associated with common colds, allergies, and sinus infections. The National Asthma Council, a non-profit organization based in Australia, stated in November 2023 that the country reported 467 deaths related to asthma in 2022, including 299 females and 168 males, indicating an upturn from 355 deaths noted in 2021. Consequently, the escalating incidence of respiratory illnesses contributes to the growth of the phenylephrine drugs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24655&type=smp

How Is the Phenylephrine Drugs Market Segmented by Several Divisions?

The phenylephrine drugs market covered in this report is segmented –

1) By Product Type: Tablets, Syrups, Eye Drops, Other Product Types

2) By Indication: Cold, Nasal Decongestion, Allergic Reaction, Eye Disease, Other Indications

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Tablets: Immediate Release Tablets, Extended Release Tablets, Combination Tablets, Orally Disintegrating Tablets

2) By Syrups: Pediatric Syrups, Adult Syrups, Sugar-Free Syrups

3) By Eye Drops: Prescription Eye Drops, Over-the-Counter (OTC) Eye Drops, Combination Eye Drops, Single-Use Eye Drops

4) By Other Product Types: Nasal Sprays, Injectable Solutions, Topical Gels or Creams, Suppositories

What are the Emerging Market Trends Driving the Growth of the Phenylephrine Drugs Industry?

Leading firms in the phenylephrine drugs market are prioritizing the creation of innovative products like ready-to-use vials to maximize convenience, cut down the time taken for preparation, and boost patient safety. These vials come pre-mixed and pre-measured which negates the need for mutation or preparation, aiding the use of phenylephrine drugs by curbing dosage inaccuracies, decreasing preparation time in crisis scenarios, and providing assured medication power and cleanliness. As an illustrative example, Hikma Pharmaceuticals PLC, a firm based in the UK specializing in the production of generic injectable and oral formulations, introduced its Phenylephrine HCl Injection, USP, branded as IMMPHENTIV, in the U.S. in December 2023. Offered in 500 mcg/5 mL and 1,000 mcg/10 mL vials, this product was the first of its kind to receive FDA approval for the 1,000 mcg/10 mL presentation in the U.S. Its main function is to elevate blood pressure in adults who experience significant hypotension primarily due to vasodilation during anesthesia. The aim is to offer hospitals a standard, pre-diluted alternative to diminish medication errors and to improve patient safety.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/phenylephrine-drugs-global-market-report

Which Regions Are Driving Growth in the Phenylephrine Drugs Market?

North America was the largest region in the phenylephrine drugs market in 2024. The regions covered in the phenylephrine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24655

This Report Delivers Insight On:

1. How big is the phenylephrine drugs market, and how is it changing globally?

2. Who are the major companies in the phenylephrine drugs market, and how are they performing?

3. What are the key opportunities and risks in the phenylephrine drugs market right now?

4. Which products or customer segments are growing the most in the phenylephrine drugs market?

5. What factors are helping or slowing down the growth of the phenylephrine drugs market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model